Progenitor cell therapy of ischemic heart disease: the new frontier.


The discovery of circulating cells capable of differentiating into vascular structures (endothelial progenitor cells) has both altered our understanding of the pathophysiology of atherosclerosis and offered the possibility of using nature's reparative mechanisms to accelerate vascular restoration and regeneration. Epidemiologic studies indicate a… (More)
DOI: 10.1517/14796678.1.1.87


4 Figures and Tables

Slides referencing similar topics